- Home
- PMVP vs TVGN Comparison
PMVP vs TVGN Comparison
Compare PMVP & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.63
Company Overview
Basic Information| Metric | PMVP | TVGN |
|---|---|---|
| Founded | 2013 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.8M | 63.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PMVP | TVGN |
|---|---|---|
| Price | $1.63 | $7.69 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 815.6K | 610.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.82 | $0.14 |
| 52 Week High | $1.88 | $10.76 |
Technical Indicators
Market Signals| Indicator | PMVP | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 66.46 | 92.70 |
| Support Level | $1.32 | $0.56 |
| Resistance Level | $1.86 | N/A |
| Average True Range (ATR) | 0.14 | 0.45 |
| MACD | 0.04 | 0.85 |
| Stochastic Oscillator | 72.67 | 68.82 |
Price Performance
Historical Comparison PMVP
TVGN
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.